ConductScience.org, home

Gene · 619554

Papers2,728

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
The Role of Circulating Therapeutic MicroRNAs in Pulmonary and Muscular Function in Post-COVID-19 Athletes.Iran J Allergy Asthma Immunol202642825909PubTator, text miningPubMed
Response to Comment on: "Fibrinogen promotes acute myelogenous leukemia progression via miR-486/GPR153 axis".Haematologica202642817842PubTator, text miningPubMed
Fibrinogen and leukemic-cell trafficking: possible implications for hyperleukocytosis and differentiation syndrome. Comment on: "Fibrinogen promotes acute myelogenous leukemia progression via miR-486/GPR153 axis".
Haematologica202642719965PubTator, text miningPubMed
Circulating muscle- and inflammation-related microRNAs in breast cancer survivorship: associations with subtype, treatment, timing, and age.Mol Biol Rep202642517980PubTator, text miningPubMed
Molecular Protein Interactions and Predictive Pathways as Biomarkers for Enhancing Volleyball Performance: A Narrative Review.Biomark Insights202642404021PubTator, text miningPubMed
Spatiotemporal delivery of exosomes and alendronate orchestrates osteoblastic and osteoclastic activity for osteoporotic bone regeneration.Bioact Mater202642383196PubTator, text miningPubMed
Epigenetic regulation of cardiac physiology and pathophysiology: biological sex matters.J Cardiovasc Aging202642369572PubTator, text miningPubMed
Extracellular vesicle cargo dynamics in the bone marrow microenvironment: from hematopoietic homeostasis to malignant transformation.Extracell Vesicle202642344609PubTator, text miningPubMed
Phase-dependent reorganization of circulating miRNA networks following short maximal exercise.Front Physiol202642311326PubTator, text miningPubMed
Heterogeneity of miRNAs in Salivary Gland Neoplasms: An Exploratory Pilot Study.J Oral Pathol Med202642184999PubTator, text miningPubMed
Retinoic acid impairs the osteogenic differentiation of BMSCs via the miR-486/FOXO1 axis: a therapeutic target for bone loss.Biochem Pharmacol202642150697PubTator, text miningPubMed
Fibrinogen promotes acute myelogenous leukemia progression via miR-486/GPR153 axis.Haematologica202642095237PubTator, text miningPubMed
CSDE1 promotes passenger strand cleavage of miR-486.RNA Biol202641905768PubTator, text miningPubMed
Evaluation of the Cytotoxicity of Biochar Aqueous Extract in Caco-2 Cells: Time-Dependent Regulation of Apoptosis, Associated with miRNA Modulation.Molecules202641900088PubTator, text miningPubMed
Exosomes in diabetic kidney disease: pathogenesis, biomarker discovery, and emerging therapeutics-a comprehensive systematic review.Ren Fail202641845912PubTator, text miningPubMed
Type 2 diabetes mellitus associated microRNAs in tuberculosis susceptibility: a systematic review and bioinformatic analysis.Front Endocrinol (Lausanne)202641809532PubTator, text miningPubMed
Exosomal non-coding RNAs in autoimmune diseases: molecular mechanisms and potential applications.Front Immunol202641798919PubTator, text miningPubMed
Assessing the contributions of noncoding RNAs in acute myeloid leukemia.Blood Neoplasia202641798679PubTator, text miningPubMed
Molecular Insights into the Regulatory Mechanisms Mediated by Hypoxia-Conditioned Skeletal Muscle Exosomal miRNAs.Biomark Insights202641783906PubTator, text miningPubMed
Metabolic Overdrive in Elite Sport: A Systems Model of AMPK-mTOR Oscillation, NAD+ Economy, and Epigenetic Drift.Int J Mol Sci202641751953PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/619554/papers